High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most commonly cancers with poor prognosis and drug response. Identifying accurate therapeutic targets would facilitate precision treatment and prolong survival for HCC. In this study, we analyzed liver hepatocellular carcinoma (LIHC) RNA sequencing (RNA-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Songwei, Huang, Jian, Yang, Fan, Zeng, Haiping, Tong, Yuyun, Li, Kejia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154901/
https://www.ncbi.nlm.nih.gov/pubmed/34040099
http://dx.doi.org/10.1038/s41598-021-90507-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154901/
https://www.ncbi.nlm.nih.gov/pubmed/34040099
http://dx.doi.org/10.1038/s41598-021-90507-w

Ejemplares similares